Article info

Download PDFPDF
Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial

Authors

  1. Correspondence to Dr Giorgio Bogani, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; giorgiobogani{at}yahoo.it
View Full Text

Citation

Bogani G, Lalli L, Casarin J, et al
Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial

Publication history

  • Received February 27, 2024
  • Accepted April 16, 2024
  • First published April 23, 2024.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.